A newly intervention strategy in preeclampsia: Targeting PD‐1/Tim‐3 signaling pathways to modulate the polarization of decidual macrophages
- 30 November 2021
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 36 (1) , e22073
Abstract
Programmed cell death‐1 (PD‐1) and T‐cell immunoglobulin mucin‐3 (Tim‐3) are important immune checkpoint receptors that prevent an overreacted maternal immune response to fetal antigens during pregnancy. Disruption of complex immune regulation mechanisms is associated with adverse pregnancy outcomes, including preeclampsia (PE). Our recent study showed that the Tim‐3 pathway was involved in the regulation of decidual macrophage polarization. Decidual macrophages polarized to the M1 phenotype may impair uterine vessel remodeling during placentation, accounting for the occurrence of PE. Co‐blockade of the PD‐1/Tim‐3 pathway was shown to successfully control tumor growth in preclinical cancer models. However, the effects of activating both PD‐1 and Tim‐3 pathways as a combined intervention strategy in PE are never reported. Herein, we observed the skew of decidual macrophage polarization toward the M1 phenotype in patients with PE and lipopolysaccharide (LPS)‐induced PE‐like rat model. Moreover, we found that the activation of PD‐1/Tim‐3 pathway by using PD‐L1 and Gal‐9 fusion proteins could alleviate the manifestation of the LPS‐induced PE‐like rats and protect their offspring. Compared with the single intervention, the combination of PD‐L1and Gal‐9 fusion proteins exhibited obvious advantages in the relief of PE‐like symptoms, trophoblast invasion, and fetal vascular development, indicating a synergistic effect of the activated PD‐1/Tim‐3 pathway. The in vitro study also revealed that the combined intervention using PD‐L1 and Gal‐9 fusion proteins inhibited the LPS‐induced M1 macrophage polarization via the synergic activation of the ERK/GSK3β/β‐catenin signaling pathway. Together, our findings provide the first evidence that simultaneous activation of PD‐1/Tim‐3 signaling pathways may have an optimal protective effect and serve as a new potential target for PE intervention.Keywords
Funding Information
- National Natural Science Foundation of China (81671490)
This publication has 39 references indexed in Scilit:
- Fetomaternal immune cross-talk and its consequences for maternal and offspring's healthNature Medicine, 2013
- Decreased Levels of Folate Receptor‐β and Reduced Numbers of Fetal Macrophages (Hofbauer Cells) in Placentas from Pregnancies with Severe Pre‐EclampsiaAmerican Journal of Reproductive Immunology, 2013
- TIM-3 Regulates Innate Immune Cells To Induce Fetomaternal ToleranceThe Journal of Immunology, 2013
- The tyrosine phosphatase SHP2 regulates recovery of endothelial adherens junctions through control of β-catenin phosphorylationMolecular Biology of the Cell, 2012
- Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2Journal of Experimental Medicine, 2012
- The blockade of immune checkpoints in cancer immunotherapyNature Reviews Cancer, 2012
- Regulation of Ubiquitination-Mediated Protein Degradation by Survival Kinases in CancerFrontiers in Oncology, 2012
- Pre-eclampsiaThe Lancet, 2010
- Erk Associates with and Primes GSK-3β for Its Inactivation Resulting in Upregulation of β-CateninMolecular Cell, 2005
- Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase BNature, 1995